Aligos Therapeutics, Inc 10-Q for FY2021 Q3
Aligos Therapeutics, Inc. (ALGS)
10-Q
2021-11-04
For: 2021-09-30
View Original
Added on
April 11, 2026
About this 10-Q
Aligos Therapeutics, Inc filed this 10-Q on November 4, 2021, covering the quarter ended September 30, 2021 (FY2021 Q3).
Headline figures
Quarter ended September 30, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $33.12M
- compared with a net loss of $33.3M a year earlier